Academic-Industrial Partnerships in Drug Discovery and Development

Drug discovery: new models for industry-academic partnerships.

The re-focusing of pharmaceutical industry research away from early discovery activities is stimulating the development of novel models of drug discovery, notably involving academia as a 'front end'. In this article the authors explore the drivers of change, the role of new entrants (universities with specialised core facilities) and novel partnership models. If they are to be sustainable and d...

Ethnobotany, Ethnopharmacology and Drug Discovery

     This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...

A Vision for Drug Discovery and Development: Novel Targets and Multilateral Partnerships

Paradigm strain exists in psychiatric pharmacology. The prevailing monoamine-based psychotropic agents have in some circumstances saved lives, robustly benefitted patient reported outcomes (e.g., quality of life measures, functionality), and have facilitated reintegration and recovery. Unfortunately, these foregoing desirable outcomes are an uncommon occurrence for most individuals who receive ...

Drug discovery gets an academic push.

The emerging academic drug-discovery sector.